FITC anti-mouse Ly-6G Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Ly-6G transfected EL-4J cell line.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.

Concentration

0.5 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 10⁶ cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser

Blue Laser (488 nm)

Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C¹⁵. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A8¹⁵. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.4¹⁶.

Additional reported applications (for the relevant formats) include: immunohistochemistry⁹ of frozen sections¹⁰ and paraffin-embedded sections¹¹, depletion^{4, 12-14}, and spatial biology (IBEX)^20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed

Product Citations

1. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
2. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
3. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
4. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
5. Valladao A, et al. 2016. J Immunol. 197(12):4541-4551. PubMed
6. Campbell IK, Leong D 2016. J Immunol. 197(11):4392-4402. PubMed
7. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
8. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
9. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
10. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
11. Long M, et al. 2017. J Immunol. 198(2):862-872. PubMed
12. Oliveira-Lima OC, et al. 2015. Immunobiology. . PubMed
13. Mandraju R, et al. 2014. J Immunol. 192:4303. PubMed
14. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
15. He R, et al. 2021. J Immunol. 206:2353. PubMed
16. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
17. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
18. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
19. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
20. Patsalos A, et al. 2019. J Immunol. 203:1532. PubMed
21. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
22. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
23. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
24. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
25. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
26. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
27. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
28. Huai W, et al. 2019. J Exp Med. 216:772. PubMed
29. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
30. Torre S, et al. 2016. Nat Immunol. 10.1038/ni.3581. PubMed
31. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
32. Wang C, et al. 2015. Sci Rep. 5: 14124. PubMed
33. Han J, et al. 2022. FEBS J. 289:417. PubMed
34. Larsen SE, et al. 2021. Sci Rep. 11:9040. PubMed
35. Castiglioni A, et al. 2015. PLoS One. 10:128094. PubMed
36. Guesdon W, et al. 2015. J Infect Dis. 212: 1332 - 1340. PubMed
37. Strother R, et al. 2016. J Immunol. 197(11):4301-4311. PubMed
38. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
39. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
40. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
41. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
42. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
43. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
44. Ueki H, et al. 2020. Nat Protoc. 15:1041. PubMed
45. Saika A, et al. 2020. FASEB Bioadv. 2:59. PubMed
46. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
47. Wang H et al. 2017. Developmental cell. 40(6):566-582 . PubMed
48. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
49. Billi AC, et al. 2019. JCI Insight. 4:8. PubMed
50. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
51. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
52. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
53. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
54. Han YH, et al. 2021. Science. 373:. PubMed
55. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
56. Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed
57. Abad C, et al. 2014. J Leukoc Biol. 95:357. PubMed
58. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
59. Liu Z, et al. 2016. J Biol Chem. 291: 1441 - 1447. PubMed
60. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
61. Na YR, et al. 2020. Cell Rep. 107643:31. PubMed
62. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
63. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
64. Wu X, et al. 2021. Elife. 10:. PubMed
65. Opzoomer JW, et al. 2021. Sci Adv. 7:eabg9518. PubMed
66. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
67. Jin RM, et al. 2017. J Immunol. 198:352. PubMed
68. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
69. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
70. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
71. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
72. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
73. Jacome-Galarza C, et al. 2011. J Bone Miner Res. 26:1207. PubMed
74. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
75. Huixin Xu et al. 2018. EMBO molecular medicine. 10(9) pii: e8931. PubMed
76. Minogue A, et al. 2014. Neurobiol Aging. 35:1442. PubMed
77. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
78. Zheng J, et al. 2020. bioRxiv. . PubMed
79. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
80. Geng S, et al. 2021. JCI Insight. 6:. PubMed
81. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
82. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
83. Chen M, et al. 2021. Oncol Lett. 21:435. PubMed
84. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
85. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
86. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
87. Roy K, et al. 2019. Immunity. 50:616. PubMed
88. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
89. Christ A, et al. 2018. Cell. 172:162. PubMed
90. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
91. Gousopoulos E, et al. 2016. Am J Pathol. 186:2193-2203. PubMed
92. Radjabova V, et al. 2015. J Immunol. 195: 3149 - 3159. PubMed
93. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
94. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
95. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
96. He J, et al. 2019. J Clin Invest. 130. PubMed
97. Yu L, et al. 2019. Elife. 8:e46677. PubMed
98. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
99. Wu M, et al. 2013. Proc Natl Acad Sci U S A. 110:9439. PubMed
100. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
101. Ericson J, et al. 2014. PLoS One. 9:108553. PubMed
102. Shih Y, et al. 2015. JPEN J Parenter Enteral Nutr. . PubMed
103. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
104. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
105. Flögel U, et al. 2021. Nat Commun. 12:5847. PubMed
106. Fischer KJ, et al. 2019. J Immunol. 202:2027. PubMed
107. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
108. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
109. Uderhardt S, et al. 2019. Cell. 177:541. PubMed
110. Hermetet F, et al. 2019. Nat Commun. 10:523. PubMed
111. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
112. Shevchenko MA, et al. 2018. J Immunol Res. 8:53. PubMed
113. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
114. Zheng J, et al. 2020. Nature. . PubMed
115. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
116. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
117. Rebecca S Dickinson et al. 2017. Wellcome open research. 0.155555556 . PubMed
118. Simpson K, et al. 2012. J Immunol. 189:5533. PubMed
119. Giampazolias E, et al. 2021. Cell. . PubMed
120. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
121. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
122. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
123. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
124. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
125. Li YT, et al. 2019. Elife. 8:e47642. PubMed
126. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
127. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
128. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
129. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
130. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
131. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
132. Qin W, et al. 2022. Bio Protoc. 12:e4287. PubMed
133. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
134. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
135. Thomas DG et al. 2018. Cell reports. 25(13):3774-3785 . PubMed
136. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
137. Chen ST et al. 2019. Cell host & microbe. 25(4):602-616 . PubMed
138. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
139. Gorina R, et al. 2014. J Immunol. 192:324. PubMed
140. Nacer A, et al. 2014. PLoS Pathog. 10:1004528. PubMed
141. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
142. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
143. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
144. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
145. Makino A, et al. 2021. iScience. 24:103201. PubMed
146. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
147. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
148. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
149. Wei Y, et al. 2021. Endocrinology. 162(8):. PubMed
150. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
151. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
152. van Geffen C, et al. 2021. Front Immunol. 12:695933. PubMed
153. Gu H, et al. 2021. Elife. 10:. PubMed
154. Issah Y, et al. 2021. Elife. 10:. PubMed
155. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
156. Danzer H, et al. 2020. Elife. 9:00. PubMed
157. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
158. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
159. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
160. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
161. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
162. Chen J, et al. 2014. Cell Res. 24:1050. PubMed
163. Xu Y, et al. 2014. Proc Natl Acad Sci U S A. 111:6371. PubMed
164. Smith LK, et al. 2021. Elife. 10:. PubMed
165. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
166. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
167. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
168. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
169. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
170. Orr MT, et al. 2019. NPJ Vaccines. 4:1. PubMed
171. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
172. Stadtmann A, et al. 2015. J Immunol. 195: 1152-1161. PubMed
173. Jia H, et al. 2016. J Immunol. 197: 859 - 871. PubMed
174. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
175. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
176. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
177. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
178. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
179. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
180. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
181. Zhang H, et al. 2022. Commun Biol. 5:916. PubMed
182. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
183. Singh N, et al. 2016. Dis Model Mech. 9: 885 - 897. PubMed
184. Cojohari O, Peppenelli M, Chan G 2016. Blood. 128: 529 - 541. PubMed
185. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
186. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
187. Chuang LT, et al. 2021. Molecules. 26:. PubMed

RRID

AB_1236488 (BioLegend Cat. No. 127605)
AB_1236494 (BioLegend Cat. No. 127606)

Antigen Details

Structure

A 21-35 kD GPI-anchorded membrane protein

Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type

Granulocytes, Macrophages, Monocytes

Biology Area

Immunology, Innate Immunity

Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID

546644 View all products for this Gene ID

UniProt

View information about Ly-6G on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Material Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Certificate of Analysis